Blocking NF-κB and AKT by Hsp90 inhibition sensitized lung adenocarcinoma cells, H23, and hepatocellular carcinoma cells, HepG2, to IAP antagonists resulting in synergistic cancer cell death45. Here, AKT1 is linked to lung adenocarcinoma.